Effect of Lactobacillus Rhamnosus HN001 in Pregnancy on Postpartum Symptoms of Depression and Anxiety: A Randomised Double-blind Placebo-controlled Trial

Overview

Journal EBioMedicine

Specialty Biomedical Engineering

Date 2017 Sep 26

PMID 28943228

Citations 154

Authors

R F Slykerman

F Hood

K Wickens

J M D Thompson

C Barthow

R Murphy

J Kang

J Rowden

P Stone

J Crane

T Stanley

P Abels

G Purdie

R Maude

E A Mitchell

Affiliations

Soon will be listed here.

Abstract

Background: Probiotics may help to prevent symptoms of anxiety and depression through several putative mechanisms.

Objective: The aim of this study was to evaluate the effect of Lactobacillus rhamnosus HN001 (HN001) given in pregnancy and postpartum on symptoms of maternal depression and anxiety in the postpartum period. This was a secondary outcome, the primary outcome being eczema in the offspring at 12months of age.

Design, Setting, Participants: A randomised, double-blind, placebo-controlled trial of the effect of HN001 on postnatal mood was conducted in 423 women in Auckland and Wellington, New Zealand. Women were recruited at 14-16weeks gestation.

Intervention: Women were randomised to receive either placebo or HN001 daily from enrolment until 6months postpartum if breastfeeding.

Outcome Measures: Modified versions of the Edinburgh Postnatal Depression Scale and State Trait Anxiety Inventory were used to assess symptoms of depression and anxiety postpartum.

Trial Registration: Australia NZ Clinical Trials Registry: ACTRN12612000196842.

Findings: 423 women were recruited between December 2012 and November 2014. 212 women were randomised to HN001 and 211 to placebo. 380 women (89.8%) completed the questionnaire on psychological outcomes, 193 (91.0%) in the treatment group and 187 (88.6%) in the placebo group. Mothers in the probiotic treatment group reported significantly lower depression scores (HN001 mean=7·7 (SD=5·4), placebo 9·0 (6·0); effect size -1·2, (95% CI -2·3, -0·1), p=0·037) and anxiety scores (HN001 12·0 (4·0), placebo 13·0 (4·0); effect size -1·0 (-1·9, -0·2), p=0·014) than those in the placebo group. Rates of clinically relevant anxiety on screening (score>15) were significantly lower in the HN001 treated mothers (OR=0·44 (0·26, 0·73), p=0·002).

Interpretation: Women who received HN001 had significantly lower depression and anxiety scores in the postpartum period. This probiotic may be useful for the prevention or treatment of symptoms of depression and anxiety postpartum.

Funding Source: Health Research Council of New Zealand (11/318) and Fonterra Co-operative Group Ltd.

Citing Articles

Exploring the microbiota-gut-brain axis: impact on brain structure and function.

Yassin L, Nakhal M, Alderei A, Almehairbi A, Mydeen A, Akour A Front Neuroanat. 2025; 19:1504065.

PMID: 40012737 PMC: 11860919. DOI: 10.3389/fnana.2025.1504065.

Alzheimer's disease and gut-brain axis: as a model.

Alves S, Lisboa-Filho P, Zilli Vieira C, Piacenti-Silva M Front Neurosci. 2025; 19:1543826.

PMID: 39967802 PMC: 11832644. DOI: 10.3389/fnins.2025.1543826.

Resilience to Global Health Challenges Through Nutritional Gut Microbiome Modulation.

Isolauri E, Laitinen K Nutrients. 2025; 17(3).

PMID: 39940253 PMC: 11821120. DOI: 10.3390/nu17030396.

Efficacy and safety of gut microbiome-targeted treatment in patients with depression: a systematic review and meta-analysis.

Pan B, Pan Y, Huang Y, Yi M, Hu Y, Lian X BMC Psychiatry. 2025; 25(1):64.

PMID: 39838303 PMC: 11753086. DOI: 10.1186/s12888-024-06438-z.

Precision Psychobiotics for Gut-Brain Axis Health: Advancing the Discovery Pipelines to Deliver Mechanistic Pathways and Proven Health Efficacy.

Slykerman R, Davies N, Vlckova K, ORiordan K, Bassett S, Dekker J Microb Biotechnol. 2025; 18(1):e70079.

PMID: 39815671 PMC: 11735468. DOI: 10.1111/1751-7915.70079.

References

Collins S, Kassam Z, Bercik P . The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr Opin Microbiol. 2013; 16(3):240-5. DOI: 10.1016/j.mib.2013.06.004. View

Cepeda M, Katz E, Blacketer C . Microbiome-Gut-Brain Axis: Probiotics and Their Association With Depression. J Neuropsychiatry Clin Neurosci. 2016; 29(1):39-44. DOI: 10.1176/appi.neuropsych.15120410. View

Dinan T, Cryan J . The impact of gut microbiota on brain and behaviour: implications for psychiatry. Curr Opin Clin Nutr Metab Care. 2015; 18(6):552-8. DOI: 10.1097/MCO.0000000000000221. View

Sanchez M, Darimont C, Panahi S, Drapeau V, Marette A, Taylor V . Effects of a Diet-Based Weight-Reducing Program with Probiotic Supplementation on Satiety Efficiency, Eating Behaviour Traits, and Psychosocial Behaviours in Obese Individuals. Nutrients. 2017; 9(3). PMC: 5372947. DOI: 10.3390/nu9030284. View

Gartlehner G, Hansen R, Carey T, Lohr K, Gaynes B, Randolph L . Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis. Int Clin Psychopharmacol. 2005; 20(2):59-69. DOI: 10.1097/00004850-200503000-00001. View

Kelly J, Allen A, Temko A, Hutch W, Kennedy P, Farid N . Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects. Brain Behav Immun. 2016; 61:50-59. DOI: 10.1016/j.bbi.2016.11.018. View

Hill C, Guarner F, Reid G, Gibson G, Merenstein D, Pot B . Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014; 11(8):506-14. DOI: 10.1038/nrgastro.2014.66. View

Webster M, Thompson J, Mitchell E, Werry J . Postnatal depression in a community cohort. Aust N Z J Psychiatry. 1994; 28(1):42-9. DOI: 10.3109/00048679409075844. View

Wallace C, Milev R . The effects of probiotics on depressive symptoms in humans: a systematic review. Ann Gen Psychiatry. 2017; 16:14. PMC: 5319175. DOI: 10.1186/s12991-017-0138-2. View

10.

Battle C, Salisbury A, Schofield C, Ortiz-Hernandez S . Perinatal antidepressant use: understanding women's preferences and concerns. J Psychiatr Pract. 2013; 19(6):443-53. PMC: 4277178. DOI: 10.1097/01.pra.0000438183.74359.46. View

11.

Romijn A, Rucklidge J, Kuijer R, Frampton C . A double-blind, randomized, placebo-controlled trial of Lactobacillus helveticus and Bifidobacterium longum for the symptoms of depression. Aust N Z J Psychiatry. 2017; 51(8):810-821. PMC: 5518919. DOI: 10.1177/0004867416686694. View

12.

Carabotti M, Scirocco A, Maselli M, Severi C . The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol. 2015; 28(2):203-209. PMC: 4367209. View

13.

Rao A, Bested A, Beaulne T, Katzman M, Iorio C, Berardi J . A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog. 2009; 1(1):6. PMC: 2664325. DOI: 10.1186/1757-4749-1-6. View

14.

Barrera-Bugueno C, Realini O, Escobar-Luna J, Sotomayor-Zarate R, Gotteland M, Julio-Pieper M . Anxiogenic effects of a Lactobacillus, inulin and the synbiotic on healthy juvenile rats. Neuroscience. 2017; 359:18-29. DOI: 10.1016/j.neuroscience.2017.06.064. View

15.

Dinan T, Cryan J . Mood by microbe: towards clinical translation. Genome Med. 2016; 8(1):36. PMC: 4822287. DOI: 10.1186/s13073-016-0292-1. View

16.

Grace S, Evindar A, Stewart D . The effect of postpartum depression on child cognitive development and behavior: a review and critical analysis of the literature. Arch Womens Ment Health. 2003; 6(4):263-74. DOI: 10.1007/s00737-003-0024-6. View

17.

Wickens K, Black P, Stanley T, Mitchell E, Fitzharris P, Tannock G . A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2008; 122(4):788-794. DOI: 10.1016/j.jaci.2008.07.011. View

18.

Selhub E, Logan A, Bested A . Fermented foods, microbiota, and mental health: ancient practice meets nutritional psychiatry. J Physiol Anthropol. 2014; 33:2. PMC: 3904694. DOI: 10.1186/1880-6805-33-2. View

19.

Mi G, Zhao L, Qiao D, Kang W, Tang M, Xu J . Effectiveness of Lactobacillus reuteri in infantile colic and colicky induced maternal depression: a prospective single blind randomized trial. Antonie Van Leeuwenhoek. 2015; 107(6):1547-53. DOI: 10.1007/s10482-015-0448-9. View

20.

Cox J, Holden J, Sagovsky R . Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987; 150:782-6. DOI: 10.1192/bjp.150.6.782. View